Elisabeth M. Zeisberg

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial.

Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: design and rationale of the Reduce-MFA DZHK25 trial.

Journal: ESC heart failure
Published: February 23, 2026

Identification of serum biomarkers linking myocardial fibrosis, systolic dysfunction and outcomes in patients with severe aortic stenosis.

Identification of serum biomarkers linking myocardial fibrosis, systolic dysfunction and outcomes in patients with severe aortic stenosis.

Journal: Cardiovascular research
Published: October 07, 2025

Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis.

Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis.

Journal: Cardiovascular research
Published: July 05, 2025

Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols.

Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 20, 2025

Estimating myocardial fibrosis in aortic stenosis using the serum collagen type I C-terminal telopeptide to matrix metalloproteinase-1 ratio.

Estimating myocardial fibrosis in aortic stenosis using the serum collagen type I C-terminal telopeptide to matrix metalloproteinase-1 ratio.

Journal: MedComm
Published: September 04, 2024

Integrated single-cell RNA-seq analysis reveals mitochondrial calcium signaling as a modulator of endothelial-to-mesenchymal transition.

Integrated single-cell RNA-seq analysis reveals mitochondrial calcium signaling as a modulator of endothelial-to-mesenchymal transition.

Journal: Science advances
Published: August 09, 2024

Cardiac fibrosis as a predictor for sudden cardiac death after transcatheter aortic valve implantation.

Cardiac fibrosis as a predictor for sudden cardiac death after transcatheter aortic valve implantation.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: June 18, 2024

Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair response.

Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair response.

Journal: Clinical epigenetics
Published: March 12, 2024

Cellular and extracellular proteomic profiling of paradoxical low-flow low-gradient aortic stenosis myocardium.

Cellular and extracellular proteomic profiling of paradoxical low-flow low-gradient aortic stenosis myocardium.

Journal: Frontiers in cardiovascular medicine
Published: March 11, 2024

Single-nucleus transcriptomics reveals adrenergic and STAT3 signalling in paradoxical low-flow low-gradient-specific cardiomyocyte subclusters: implications for aortic stenosis pathogenesis and treatment.

Single-nucleus transcriptomics reveals adrenergic and STAT3 signalling in paradoxical low-flow low-gradient-specific cardiomyocyte subclusters: implications for aortic stenosis pathogenesis and treatment.

Journal: Cardiovascular research
Published: February 15, 2024

Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function.

Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: November 18, 2023

Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement.

Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement.

Journal: ESC heart failure
Published: June 27, 2023
Showing 1-12 of 54

Last Updated: 09/26/2026